These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 33408611)

  • 21. Non-linear Relationship Between Plasma Amyloid-β 40 Level and Cognitive Decline in a Cognitively Normal Population.
    Gao F; Shang S; Chen C; Dang L; Gao L; Wei S; Wang J; Huo K; Deng M; Wang J; Qu Q
    Front Aging Neurosci; 2020; 12():557005. PubMed ID: 33061905
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Semantic clustering and sleep in patients with amnestic mild cognitive impairment or with vascular cognitive impairment-no dementia.
    Sun Q; Luo L; Ren H; Wei C; Xing M; Cheng Y; Zhang N
    Int Psychogeriatr; 2016 Sep; 28(9):1493-502. PubMed ID: 27169617
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of plasma biomarkers in early diagnosis of Alzheimer's disease.
    Wang T; Xiao S; Liu Y; Lin Z; Su N; Li X; Li G; Zhang M; Fang Y
    Int J Geriatr Psychiatry; 2014 Jul; 29(7):713-9. PubMed ID: 24318929
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Distinct Neural Correlates of Executive Function by Amyloid Positivity and Associations with Clinical Progression in Mild Cognitive Impairment.
    Yoon HJ; Kim SG; Kim SH; Choo ILH; Park SH; Seo EH;
    Yonsei Med J; 2019 Oct; 60(10):935-943. PubMed ID: 31538428
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Amyloid-Independent Amnestic Mild Cognitive Impairment and Serum Apolipoprotein A1 Levels.
    Choi HJ; Seo EH; Yi D; Sohn BK; Choe YM; Byun MS; Lee JM; Woo JI; Lee DY
    Am J Geriatr Psychiatry; 2016 Feb; 24(2):144-53. PubMed ID: 26238231
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropsychological profile of amyloid-positive versus amyloid-negative amnestic Mild Cognitive Impairment.
    Alves L; Cardoso S; Silva D; Mendes T; Marôco J; Nogueira J; Lima M; Tábuas-Pereira M; Baldeiras I; Santana I; de Mendonça A; Guerreiro M
    J Neuropsychol; 2021 Apr; 15 Suppl 1():41-52. PubMed ID: 32588984
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Identifying Brain Connectivity Using Network-Based Statistics in Amnestic Mild Cognitive Impairment Stratified by β-Amyloid Positivity.
    Kim JE; Kim SW; Choi M; Seong JK; Lee JH
    Am J Alzheimers Dis Other Demen; 2019 Mar; 34(2):104-111. PubMed ID: 30497273
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Chemically treated plasma Aβ is a potential blood-based biomarker for screening cerebral amyloid deposition.
    Park JC; Han SH; Cho HJ; Byun MS; Yi D; Choe YM; Kang S; Jung ES; Won SJ; Kim EH; Kim YK; Lee DY; Mook-Jung I
    Alzheimers Res Ther; 2017 Mar; 9(1):20. PubMed ID: 28330509
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preoperative Microbiomes and Intestinal Barrier Function Can Differentiate Prodromal Alzheimer's Disease From Normal Neurocognition in Elderly Patients Scheduled to Undergo Orthopedic Surgery.
    Duan M; Liu F; Fu H; Lu S; Wang T
    Front Cell Infect Microbiol; 2021; 11():592842. PubMed ID: 33869072
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Ten-year change in plasma amyloid beta levels and late-life cognitive decline.
    Okereke OI; Xia W; Selkoe DJ; Grodstein F
    Arch Neurol; 2009 Oct; 66(10):1247-53. PubMed ID: 19822780
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of plasma β-amyloid 40 and 42 concentration with type 2 diabetes among Chinese adults.
    Peng X; Xu Z; Mo X; Guo Q; Yin J; Xu M; Peng Z; Sun T; Zhou L; Peng X; Xu S; Yang W; Bao W; Shan Z; Li X; Liu L
    Diabetologia; 2020 May; 63(5):954-963. PubMed ID: 32034441
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sleep-Wake Patterns and Cognition of Older Adults with Amnestic Mild Cognitive Impairment (aMCI): A Comparison with Cognitively Healthy Adults and Moderate Alzheimer's Disease Patients.
    Wams EJ; Wilcock GK; Foster RG; Wulff K
    Curr Alzheimer Res; 2017; 14(10):1030-1041. PubMed ID: 28545363
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Elevated Plasma Aβ42 in Cognitively Impaired Individuals Taking ACE Inhibitor Antihypertensives.
    Regenold WT; Blumenthal JB; Loreck DJ; Mordecai KL; Scarinzi G; Doddi SR; Adler L
    Am J Alzheimers Dis Other Demen; 2017 Sep; 32(6):347-352. PubMed ID: 28449585
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Plasma Aβ and PET PiB binding are inversely related in mild cognitive impairment.
    Devanand DP; Schupf N; Stern Y; Parsey R; Pelton GH; Mehta P; Mayeux R
    Neurology; 2011 Jul; 77(2):125-31. PubMed ID: 21715709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identifying biomarkers of dementia prevalent among amnestic mild cognitively impaired ethnic female patients.
    Grewal R; Haghighi M; Huang S; Smith AG; Cao C; Lin X; Lee DC; Teten N; Hill AM; Selenica MB
    Alzheimers Res Ther; 2016 Oct; 8(1):43. PubMed ID: 27756387
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Amyloid-independent functional neural correlates of episodic memory in amnestic mild cognitive impairment.
    Seo EH; Choo IL;
    Eur J Nucl Med Mol Imaging; 2016 Jun; 43(6):1088-95. PubMed ID: 26613793
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ultrasensitive Detection of Plasma Amyloid-β as a Biomarker for Cognitively Normal Elderly Individuals at Risk of Alzheimer's Disease.
    Chatterjee P; Elmi M; Goozee K; Shah T; Sohrabi HR; Dias CB; Pedrini S; Shen K; Asih PR; Dave P; Taddei K; Vanderstichele H; Zetterberg H; Blennow K; Martins RN
    J Alzheimers Dis; 2019; 71(3):775-783. PubMed ID: 31424403
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of Yi-Zhi-An-Shen granules on cognition and sleep quality in older adults with amnestic mild cognitive impairment: protocol for a randomized, double-blind, placebo-controlled trial.
    Yue S; He T; Li B; Qu Y; Peng H; Chen J; Lei M; Chen C; Wu W
    Trials; 2019 Aug; 20(1):518. PubMed ID: 31429790
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Plasma neopterin level as a marker of peripheral immune activation in amnestic mild cognitive impairment and Alzheimer's disease.
    Parker DC; Mielke MM; Yu Q; Rosenberg PB; Jain A; Lyketsos CG; Fedarko NS; Oh ES
    Int J Geriatr Psychiatry; 2013 Feb; 28(2):149-54. PubMed ID: 22539447
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Qualitative Comparison of Semantic Memory Impairment in Patients with Amnestic Mild Cognitive Impairment Based on β-Amyloid Status.
    Kim JE; Park SH; Hong YJ; Hwang J; Han NE; Lee SM; Roh JH; Kim JS; Lee JH
    J Clin Neurol; 2019 Jan; 15(1):27-37. PubMed ID: 30375759
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.